Xiaobang Gao

Statistics

Publications

Citations

111

H-Index

Active since

2000

Affiliations

University of North Carolina at Chapel Hill(Current)

Xiaobang Gao is an author at University of North Carolina at Chapel Hill specializing in receptor pharmacology, platelet inhibition, and medicinal heterocycles.

Publications per year

2000–2022

Publications

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

Gary Herman, Meagan P. O’Brien, Eduardo Forleo‐Neto et al. · The Lancet Infectious Diseases · 2022 · 41 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +8

Heterotricyclic Himbacine Analogs as Potent, Orally Active Thrombin Receptor (Protease Activated Receptor-1) Antagonists

Mariappan V. Chelliah, Samuel Chackalamannil, Yan Xia et al. · Journal of Medicinal Chemistry · 2007 · 35 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

A facile chemoselective deprotection of the p-methoxybenzyl group

Wensheng Yu, Mei Su, Xiaobang Gao et al. · Tetrahedron Letters · 2000 · 35 citations

Natural Sciences, Chemistry, Organic Chemistry +6

1–3 of 3